Acura Pharmaceuticals reported -387000 in Net Income for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acelrx Pharmaceuticals ACRX:US $ -8.67M 0.76M
Acura Pharmaceuticals ACUR:US -387000 128K
Intra Cellular Therapies ITCI:US $ -72.12M 13.62M
Johnson & Johnson JNJ:US $ 5149M 413M
Nektar Therapeutics NKTR:US $ -90.39M 55.25M
Pfizer PFE:US $ 7863M 4470M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.8M
Shionogi 4507:JP Y 43184M 25314M
Sun Pharmaceuticals SUNP:IN IR -22772.5M 43360.5M
Teva Pharmaceutical TEVA:IT -955000000 797M
Xeris Pharmaceuticals Inc XERS:US -33714000 17.08M